Periodic Reporting for period 1 - GALILEO (The first wide range flow sensor to unlock microfluidic cell analyses for preclinical studies)

The average cost of developing a new drug is a staggering 1 billion €. All new drug candidates in the development pipeline must undergo a thorough preclinical screening for safety and efficacy before being trialed in humans. Today this requires the use of models that include...